SCHEMBL7246155

SCHEMBL7246155

Cn1c(CCc2ccc(C#N)cc2)nc2cc(C(=O)N(CCN(Cc3ccccc3)Cc3ccccc3)C3CCCCC3)ccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 1/20 0.47
ITK Q08881 12/20 0.44
HDAC1 Q13547 2/20 0.41
AURKA O14965 1/20 0.40
MAP4K4 O95819 1/20 0.40
CHEK2 O96017 1/20 0.40
PRKCG P05129 1/20 0.40
PHKG2 P15735 1/20 0.40
MARK3 P27448 1/20 0.40
FLT3 P36888 1/20 0.40
CSNK1A1 P48729 1/20 0.40
CSNK1D P48730 1/20 0.40
CLK2 P49760 1/20 0.40
GSK3B P49841 1/20 0.40
IRAK1 P51617 1/20 0.40
RPS6KA3 P51812 1/20 0.40
NEK4 P51957 1/20 0.40
CSNK1G2 P78368 1/20 0.40
MAP4K2 Q12851 1/20 0.40
PRKAA1 Q13131 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7245225 0.89 F2 (0.59) F2ITKHDAC1
SCHEMBL7246239 0.88 ITK (0.46) F2ITKAURKAMAP4K4CHEK2
SCHEMBL6775078 0.83 ITK (0.43) F2ITKAURKAMAP4K4CHEK2
SCHEMBL7245070 0.81 F2 (0.53) F2HDAC1HDAC8
SCHEMBL7244643 0.80 F2 (0.50) F2HDAC1HDAC8
SCHEMBL7252107 0.78 F2 (0.49) F2HDAC1HDAC8
SCHEMBL7247840 0.78 NSD2 (0.52) F2ITKHDAC1AURKAMAP4K4
SCHEMBL7243952 0.77 F2 (0.59) F2ITK
SCHEMBL7245210 0.77 F2 (0.51) F2ITKHDAC1HDAC8
SCHEMBL7245646 0.77 F2 (0.63) F2ITKHDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6512000-B1 Aminocarbonyl- substituted benzimidazole derivatives for the treatment of diseases in which inhibition of tryptase is of therapeutic such as for treating an inflammatory or allergic disease BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-01-28 US disclosed